The Parkinson's Support Group will hold its monthly meeting at 2 p.m. on Wednesday, Jan. 8, at Sanford Health Windsong, 1010 Anne St. NW. The group meets at 2 p.m. on the second Wednesday of each ...
Psilocybin is under development for the treatment of Parkinson’s disease, bipolar disorder and chronic pain. The drug candidate is a tryptamine alkaloid which acts by targeting 5 hydroxy tryptamine 1A ...
ASN-90 is under clinical development by Asceneuron and currently in Phase I for Parkinson’s Disease. According to GlobalData, Phase I drugs for Parkinson’s Disease have a 72% phase transition success ...
Allan Border speaks candidly on Sam Konstas, his hopes of finally handing his trophy back to Australia, the friends he’s lost along the way, and his battle with Parkinson’s disease.